Conversely, CFCS is genetically heterogeneous and caused by heterozygous activating mutations in the BRAF, MAP2K1, MAP2K2 and KRAS genes, leading to a more variable clinical presentation [4]. The gene discussed is MAP2K1; the disease is cardiofaciocutaneous syndrome 1.